Overview
CYT003-QbG10 for Treatment of Allergic Asthma Bronchial
Status:
Completed
Completed
Trial end date:
2010-11-01
2010-11-01
Target enrollment:
0
0
Participant gender:
All
All
Summary
The purpose of the study is to test whether treatment with CYT003-QbG10 can improve asthma symptoms in patients with allergic bronchial asthma. The active treatment will be compared against placebo.Phase:
Phase 2Accepts Healthy Volunteers?
NoDetails
Lead Sponsor:
Cytos Biotechnology AG
Criteria
Inclusion Criteria:- Persistent allergic asthma bronchial requiring long-term treatment with inhaled
corticosteroids
- Further criteria as defined in the study protocol
Exclusion Criteria:
- Use of oral corticosteroids within past 3 months
- Hospitalization for asthma exacerbation within past 6 months
- Uncontrolled asthma
- Contraindication to any study test or procedure
- Further criteria as defined in the study protocol